Brigit Biofarmaka Teknologi Tbk. vs Lancartama Sejati Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume), while Lancartama Sejati Tbk. trades at Rp260 (market cap 314.4B, 15.18M 24h volume). The key difference: Lancartama Sejati Tbk. is the larger of the two by market cap, and Lancartama Sejati Tbk. is more actively traded (15.18M versus 62.5K). Which is the better fit depends on your goals.
| OBAT | TAMA | |
|---|---|---|
Market Cap | 164.65B | 314.4B |
Volume | 62.5K | 15.18M |
Lot | 625 | 151.79K |
Turnover | 15.03M | 4.08B |
Average Price | 240.55 | 268.58 |
Value | 15.03M | 4.08B |
Indicative Equilibrium Price | 238 | 260 |
Indicative Equilibrium Volume | 100 | 10.32K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Lancartama Sejati Tbk (the Company) was established based on notary deed No. 12 dated June 01, 1990 of Sugiri Kadarisman, SH., notary in Jakarta.
Read more on TAMA →